ADGRD1 and glioblastoma: Indeed, while GPR133 is diffusely expressed in GBM tumors, including within the tumor bulk and infiltrating edges, we qualitatively identified increased expression in these pseudopalisading cells surrounding necrotic cores (Supplementary Figure 3).